METHODS OF USE & COMPOSITIONS OF ANTIBIOTIC ALTERNATIVES IN LIVESTOCK

    公开(公告)号:US20210386092A1

    公开(公告)日:2021-12-16

    申请号:US16326446

    申请日:2017-08-20

    摘要: This invention relates to the development of products that are alternatives to antibiotics with medically important human therapeutic uses for livestock meat and protein production efficiency. These products will be used to replace antibiotics used to rapidly increase lean muscle mass with specific feed regimens. The present invention is for the identification of non-human antibiotic products to be used with different feed regimens for livestock growth and meat promotion that include prebiotic supplements and keystone species probiotics that produce the desired growth promotion phenotypic effects. The present invention includes the identification of enterotypes that can be used as targets for recapitulation by compounds that are screened to produce the desired phenotype.

    Unique identification of devices using color detection
    5.
    发明授权
    Unique identification of devices using color detection 有权
    使用颜色检测的设备的独特识别

    公开(公告)号:US08325020B2

    公开(公告)日:2012-12-04

    申请号:US13017936

    申请日:2011-01-31

    IPC分类号: H04Q5/22

    摘要: Methods and apparatus for uniquely identifying wireless devices in close physical proximity are described. When two wireless devices are brought into close proximity, one of the devices displays an optical indicator, such as a light pattern. This device then sends messages to other devices which are within wireless range to cause them to use any light sensor to detect a signal. In an embodiment, the light sensor is a camera and the detected signal is an image captured by the camera. Each device then sends data identifying what was detected back to the device displaying the pattern. By analyzing this data, the first device can determine which other device detected the indicator that it displayed and therefore determine that this device is within close physical proximity. In an example, the first device is an interactive surface arranged to identify the wireless addresses of devices which are placed on the surface.

    摘要翻译: 描述用于唯一地识别物理上接近的无线设备的方法和装置。 当两个无线设备紧密接近时,其中一个设备显示光学指示符,例如光图案。 然后,该设备向无线范围内的其他设备发送消息,使其使用任何光传感器来检测信号。 在一个实施例中,光传感器是相机,并且检测到的信号是由照相机拍摄的图像。 然后,每个设备发送识别检测到的内容的数据,显示该模式的设备。 通过分析该数据,第一设备可以确定哪个其他设备检测到其显示的指示符,并且因此确定该设备处于紧密的物理接近度内。 在一个示例中,第一设备是布置成识别放置在表面上的设备的无线地址的交互式表面。

    Combined EAS/RFID tag
    7.
    发明申请
    Combined EAS/RFID tag 有权
    组合EAS / RFID标签

    公开(公告)号:US20100001079A1

    公开(公告)日:2010-01-07

    申请号:US12380404

    申请日:2009-02-26

    IPC分类号: G06K19/067

    摘要: A combined EAS/RFID tag including an EAS circuit and a first RFID circuit is disclosed. The EAS circuit has at least one capacitor and the RFID circuit has a main antenna wherein at least a part of the capacitor of the EAS circuit provides at least a part of the main antenna of the RFID circuit. The EAS circuit may include two capacitors and each capacitor may include first and second plates on first and second sides of a substrate wherein one plate of each capacitor forms part of the main antenna of the RFID circuit.

    摘要翻译: 公开了包括EAS电路和第一RFID电路的组合EAS / RFID标签。 EAS电路具有至少一个电容器,并且RFID电路具有主天线,其中EAS电路的至少一部分电容器提供RFID电路的主天线的至少一部分。 EAS电路可以包括两个电容器,并且每个电容器可以包括在衬底的第一和第二侧上的第一和第二板,其中每个电容器的一个板形成RFID电路的主天线的一部分。

    Methods for increasing meat production in livestock animals

    公开(公告)号:US11533933B2

    公开(公告)日:2022-12-27

    申请号:US16326446

    申请日:2017-08-20

    摘要: This invention relates to the development of products that are alternatives to antibiotics with medically important human therapeutic uses for livestock meat and protein production efficiency. These products will be used to replace antibiotics used to rapidly increase lean muscle mass with specific feed regimens. The present invention is for the identification of non-human antibiotic products to be used with different feed regimens for livestock growth and meat promotion that include prebiotic supplements and keystone species probiotics that produce the desired growth promotion phenotypic effects. The present invention includes the identification of enterotypes that can be used as targets for recapitulation by compounds that are screened to produce the desired phenotype.

    ANTIMICROBIAL DRUG METHODS OF USE & THERAPEUTIC COMPOSITIONS

    公开(公告)号:US20210369675A1

    公开(公告)日:2021-12-02

    申请号:US16326433

    申请日:2017-08-19

    摘要: This invention relates to the medical use of an antimicrobial agent, racemic Ornidazole, its (R) and (S) enantiomers, or pharmaceutically acceptable salts or esters thereof, and to methods of treatment which involve treating a subject with Ornidazole. The racemic (rac)-ornidazole, its enantiomers, or pharmaceutically acceptable salts or esters thereof, may be used in combination with other actives, and in particular, beta lactam antibiotics combined with beta lactamase inhibitors, like co-amoxiclay. The invention also relates to pharmaceutical formulations and compositions comprising (rac)-ornidazole, (R)-ornidazole, (S)-ornidazole, or pharmaceutically acceptable salts or esters thereof, and/or other actives and their use with bio-threat pathogens that utilize a mechanism of tolerance or resistance by facultatively switching from aerobic to anaerobic confirmations and by switching back and forth from planktonic to biofilm forms.

    Antimicrobial drug synthesis and therapeutic compositions

    公开(公告)号:US11135200B2

    公开(公告)日:2021-10-05

    申请号:US16885585

    申请日:2020-05-28

    摘要: This invention relates to the medical use of an antimicrobial agent, racemic Ornidazole, its (R) and (S) enantiomers, or pharmaceutically acceptable salts or esters thereof, and to methods of treatment which involve treating a subject with Ornidazole. The racemic (rac)-ornidazole, its enantiomers, or pharmaceutically acceptable salts or esters thereof, may be used in combination with other actives. The invention also relates to pharmaceutical formulations and compositions comprising (rac)-ornidazole, (R)-ornidazole, (S)-ornidazole, or pharmaceutically acceptable salts or esters thereof, and/or other actives as well as methods to stereoselectively manufacture the enantiomers.